Search

Zoetis Inc

Cerrado

SectorSanidad

79.42 -3.25

Resumen

Variación precio

24h

Actual

Mínimo

79.12

Máximo

79.93

Métricas clave

By Trading Economics

Ingresos

90M

691M

Ventas

206M

2.5B

P/B

Media del Sector

13.12

51.78

BPA

1.87

Rentabilidad por dividendo

2.58

Margen de beneficios

27.998

Empleados

14,500

EBITDA

107M

1B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+10.71% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

2.58%

1.96%

Fecha Próximo Dividendo

1 dic 2026

Próxima Fecha de Ex Dividendo

19 ene 2027

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

2B

34B

Apertura anterior

82.67

Cierre anterior

79.42

Zoetis Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

6 nov 2026, 23:06 UTC

Zoetis Inc shares are trading slightly lower in after-market hours, marking a third consecutive session of declines despite a smaller cumulative return.

5 nov 2026, 23:11 UTC

Zoetis Inc shares are modestly lower in after-market trading, reflecting broader market declines despite positive economic indicators released today.

4 nov 2026, 23:02 UTC

News

Zoetis proposes divesting certain assets in Australia, with a regulatory review expected to conclude in early 2027, according to an SEC filing.

2 nov 2026, 21:04 UTC

Zoetis Inc shares are advancing, breaking a trend of higher daily closes since Friday, despite a broader market experiencing a downward shift.

30 oct 2026, 23:51 UTC

News

BTIG suspended its Buy rating on Zoetis Inc, contributing to a modest decline in the stock during after-market hours.

29 oct 2026, 23:06 UTC

Zoetis Inc shares traded modestly lower in after-market hours, retracing from an initial slight rise to its opening level following Thursday's close.

28 oct 2026, 23:06 UTC

In after-market trading, Zoetis Inc is effectively unchanged since Wednesday's close, remaining above its 20-day moving average and near the upper end of its one-month range.

27 oct 2026, 23:06 UTC

News

UBS maintains Neutral rating on Zoetis Inc and raises price target to $85, following an announcement made after the market closed on Tuesday.

26 oct 2026, 23:01 UTC

Zoetis Inc shares declined modestly in after-market trading, retracing from a brief peak and remaining lower than Monday's close.

23 oct 2026, 19:56 UTC

Zoetis Inc shares fell sharply during Friday's trading session, reaching a notable low late morning.

22 oct 2026, 20:07 UTC

Zoetis Inc shares are advancing, showing strong momentum and peaking around mid-afternoon, while remaining well above its 20-day moving average.

21 oct 2026, 23:41 UTC

Zoetis Inc shares are trading modestly lower in after-market hours, following the broader market's significant decline.

20 oct 2026, 22:02 UTC

News

Zoetis Inc. received FDA approval for Convenia RTU, an antibiotic for treating bacterial skin infections in dogs, set to launch in Q1 2027.

19 oct 2026, 23:51 UTC

Zoetis Inc shares traded modestly lower in after-market hours, following a notable decline that has continued since Monday's close.

16 oct 2026, 23:01 UTC

Zoetis Inc is trading lower in after-market hours, reflecting broader market declines amid stronger-than-expected inflation data and cautious sentiment on AI investments.

15 oct 2026, 23:21 UTC

Zoetis Inc. has gained in after-market trading, reaching its highest cumulative return since Thursday's close, following a significant increase from a recent low.

14 oct 2026, 19:36 UTC

Macro Event

Shares of Zoetis Inc are advancing amid key inflation reports, with a core inflation rate of 2.6% for September, slightly above expectations.

13 oct 2026, 20:07 UTC

Zoetis Inc shares are declining, falling steadily after reaching a high at the market open.

12 oct 2026, 20:06 UTC

Zoetis Inc shares are advancing, reaching their highest point of the day before market close and maintaining a position above the 20-day moving average.

10 oct 2026, 00:01 UTC

Zoetis Inc. is declining in after-market trading, reversing recent gains and dropping below Friday's close.

9 oct 2026, 23:30 UTC

Zoetis Inc declined in after-market trading, moving lower since Friday's close, contrasting with recent upward trends.

8 oct 2026, 20:07 UTC

Zoetis Inc shares advanced, reflecting a notable increase since Wednesday's close, despite pulling back slightly from earlier session highs.

7 oct 2026, 19:15 UTC

Zoetis Inc shares are modestly higher, peaking at nearly 0.94% intraday, maintaining a position around the middle of their one-month trading range.

6 oct 2026, 23:05 UTC

Zoetis Inc's shares declined in after-market trading, remaining near the low end of its trading range since Tuesday's close.

5 oct 2026, 21:02 UTC

Zoetis Inc. is trading modestly lower in after-market hours, experiencing unusual volatility and remaining below its 20-day moving average.

1 oct 2026, 20:07 UTC

Zoetis Inc shares fell sharply, continuing a downward trend with four consecutive sessions of declines, closing well below its 20-day moving average.

30 sept 2026, 20:02 UTC

Zoetis Inc shares fell sharply after an initial gain, currently trading below Tuesday's close and near the lower end of its one-month range.

29 sept 2026, 20:07 UTC

Zoetis Inc shares are declining, reaching a low just before noon and trading well below their 20-day moving average.

28 sept 2026, 22:01 UTC

Zoetis Inc. is trading modestly lower in after-market hours, continuing a downward trend with a cumulative return nearly 0.75% below Monday's close.

25 sept 2026, 20:07 UTC

Zoetis Inc shares are trading higher amid overall market momentum, though they remain below their 20-day moving average and near the lower end of their one-month range.

Comparación entre iguales

Cambio de precio

Zoetis Inc previsión

Precio Objetivo

By TipRanks

10.71% repunte

Estimación a 12 Meses

Media 87.9 USD  10.71%

Máximo 115 USD

Mínimo 74 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Zoetis Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

12 ratings

4

Comprar

8

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat